73 related articles for article (PubMed ID: 16809941)
1. Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model.
Iki K; Pour PM
Pancreatology; 2006; 6(4):406-13. PubMed ID: 16809941
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
[TBL] [Abstract][Full Text] [Related]
3. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic staining of OCT4 is a highly sensitive marker of adrenal medullary-derived tissue.
Alexander RE; Cheng L; Grignon DJ; Idrees M
Am J Surg Pathol; 2013 May; 37(5):727-33. PubMed ID: 23588367
[TBL] [Abstract][Full Text] [Related]
5. Modification of pancreatic carcinogenesis in the hamster model. 2. The effect of partial pancreatectomy.
Pour PM; Donnelly T; Stepan K; Muffly K
Am J Pathol; 1983 Jan; 110(1):75-82. PubMed ID: 6295175
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic OCT4 staining is a sensitive marker of neuroendocrine differentiation.
Alexander RE; Cheng L; Grignon DJ; Idrees MT
Hum Pathol; 2014 Jan; 45(1):27-32. PubMed ID: 24182453
[TBL] [Abstract][Full Text] [Related]
7. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
8. Islet cells contribute to pancreatic carcinogenesis in an animal model.
El-Ghamari M; Bergmann F; Schmied BM; Weitz J; Ulrich A
Pancreas; 2011 Mar; 40(2):242-6. PubMed ID: 21178650
[TBL] [Abstract][Full Text] [Related]
9. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
11. Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis.
Wen J; Park JY; Park KH; Chung HW; Bang S; Park SW; Song SY
Pancreas; 2010 Jul; 39(5):622-6. PubMed ID: 20173672
[TBL] [Abstract][Full Text] [Related]
12. Modification of pancreatic carcinogenesis in the hamster model. X. Effect of streptozotocin.
Pour PM; Patil K
J Natl Cancer Inst; 1983 Nov; 71(5):1059-65. PubMed ID: 6316009
[TBL] [Abstract][Full Text] [Related]
13. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy.
Sung MT; Jones TD; Beck SD; Foster RS; Cheng L
Hum Pathol; 2006 Jun; 37(6):662-7. PubMed ID: 16733205
[TBL] [Abstract][Full Text] [Related]
14. Modification of pancreatic carcinogenesis in the hamster model. XII. Dose-related effect of ethanol.
Pour PM; Reber HA; Stepan K
J Natl Cancer Inst; 1983 Nov; 71(5):1085-7. PubMed ID: 6316010
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
16. Islet cells as a component of pancreatic ductal neoplasms. I. Experimental study: ductular cells, including islet cell precursors, as primary progenitor cells of tumors.
Pour P
Am J Pathol; 1978 Feb; 90(2):295-316. PubMed ID: 341720
[TBL] [Abstract][Full Text] [Related]
17. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas.
Scarpelli DG; Rao MS; Subbarao V
Cancer Res; 1983 Feb; 43(2):611-6. PubMed ID: 6848182
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation between pancreatic DNA damage and species specificity in response to N-nitrosobis(2-oxopropyl)amine.
Zurlo J; Longnecker DS
J Natl Cancer Inst; 1983 Sep; 71(3):523-8. PubMed ID: 6604188
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Mathiak G; Brand RE; Buechler MW; Pour PM
Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
